Protagonist Therapeutics, Inc. (PTGX)
82.76
-0.33
(-0.40%)
USD |
NASDAQ |
Feb 20, 16:00
82.77
+0.01
(+0.01%)
After-Hours: 20:00
Protagonist Therapeutics Shareholders Equity (Quarterly) : 645.44M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 81.54B |
| ADMA Biologics, Inc. | 431.19M |
| Glaukos Corp. | 656.16M |
| Krystal Biotech, Inc. | 1.220B |
| ACADIA Pharmaceuticals, Inc. | 917.27M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 701.69M |
| Total Liabilities (Quarterly) | 56.25M |
| Debt to Equity Ratio | 0.0167 |
| Current Ratio | 13.05 |
| Net Debt Paydown Yield | 0.00% |